Advanced Bionics AG
14
4
5
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
22%
2 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Retrospective Analysis of Long-term Speech Performance in Cochlear Implant Recipients Using Electro-acoustic Stimulation
Role: lead
Safety and Performance of HiRes Ultra/Ultra 3D Cl Mid-Scala Electrodes in Adults With Severe-to-profound Hearing Loss
Role: lead
Hearing and Structure Preservation Via ECochG
Role: lead
Investigation of Sky Automatic Technologies in Pediatrics
Role: collaborator
Safety and Performance of Ultra/Ultra 3D Cl With HiFocus SlimJ Electrode in Adults With Severe-to-profound Hearing Loss
Role: lead
Evaluation of Remote Programming of Cochlear Implants in Routine Cochlear Implant Follow-up
Role: lead
Evaluation of a Binaural Beamformer (StereoZoom) in a Virtual Acoustic Environment and in Real Life
Role: lead
Investigation of the Automatic Technology on the Naída M Hearing Devices
Role: lead
Retrospective Analysis of Speech Performance Using the HiRes Ultra and HiRes Ultra 3D Cochlear Implant
Role: lead
Investigation of the Naída CI M90 Sound Processor in Various Acoustic Scenarios
Role: lead
Bimodal, CROS and Severe Profound Hearing Loss Study
Role: collaborator
Benefits of the HiResolutionTM Bionic Ear System in Adults With Low-Frequency Hearing
Role: lead
Evaluation of Different Phone Solutions in CI and Hearing Aid Users and Bimodal Recipients
Role: lead
Benefits of a Contralateral Routing of Signals (CROS) System in Unilateral CI-recipients
Role: lead
All 14 trials loaded